Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
17.06. | Syra Health Corp - 8-K, Current Report | 1 | SEC Filings | ||
27.05. | Syra Health Wins $5.8 Mln Indiana Contract To Lead Child Mental Health Access Site | 1 | RTTNews | ||
20.05. | Syra Health Corp - 8-K, Current Report | 1 | SEC Filings | ||
SYRA HEALTH Aktie jetzt für 0€ handeln | |||||
20.05. | Syra Health embarks on search for new CEO | 1 | Investing.com | ||
20.05. | Syra Health beginnt Suche nach neuem CEO | 2 | Investing.com Deutsch | ||
20.05. | Syra Health Board Begins CEO Search to Drive Growth | 78 | PR Newswire | CARMEL, Ind., May 20, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB: SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering... ► Artikel lesen | |
09.05. | Syra Health GAAP EPS of -$0.04, revenue of $1.86M | 1 | Seeking Alpha | ||
08.05. | Syra Health Corp - 8-K, Current Report | 1 | SEC Filings | ||
08.05. | Syra Health Corp - 10-Q, Quarterly Report | 1 | SEC Filings | ||
08.05. | Syra Health Announces First Quarter Revenue of $1.9 Million, Up 6% YoY | 72 | PR Newswire | Revenue increase led by Population Health's 261% YoY Expansion
Gross Margin Improves Substantially to 31.7%, up 14.6 Percentage Points YoY
Continued Efficiency Gains... ► Artikel lesen | |
08.04. | Syra Health Corp - 8-K, Current Report | 4 | SEC Filings | ||
01.04. | Syra Health to delist from Nasdaq Capital Market | 1 | Investing.com | ||
01.04. | Syra Health announces voluntary delisting from Nasdaq | 4 | Seeking Alpha | ||
01.04. | Syra Health kündigt Rückzug vom NASDAQ Capital Market an | 2 | Investing.com Deutsch | ||
01.04. | Syra Health Announces Voluntary Delisting from the Nasdaq Capital Market | 88 | PR Newswire | CARMEL, Ind., April 1, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering... ► Artikel lesen | |
13.03. | Syra Health sichert Vertragsverlängerung im Wert von 660.000 US-Dollar | 1 | Investing.com Deutsch | ||
13.03. | Syra Health secures $660,000 population health contract extension | 1 | Seeking Alpha | ||
11.03. | Syra Health Corp - 8-K, Current Report | 2 | SEC Filings | ||
11.03. | Syra Health Corp - 10-K, Annual Report | 1 | SEC Filings | ||
11.03. | Syra Health Announces Full-Year Revenue of $8.0 Million, Up 45% YoY | 223 | PR Newswire | 2024 Population Health Revenue Acceleration to 132% YoY
Q4 2024 Net Losses Cut Nearly in Half Compared to Q4 2023, Highlighting Major Efficiency Gains
Continued... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
SERNOVA BIOTHERAPEUTICS | 0,109 | +1,87 % | Sernova Biotherapeutics, Inc.: Sernova Appoints Jonathan Rigby as Interim Chair | LONDON, Ontario and BOSTON, June 02, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing its... ► Artikel lesen | |
ATOSSA THERAPEUTICS | 0,745 | +0,13 % | Atossa Genetics Year-end 2024 slides: (Z)-endoxifen shows promise, expenses decline | ||
PING AN HEALTHCARE | 0,946 | +9,49 % | PA GOODDOCTOR (01833): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 26 JUNE 2025 | ||
MOUNTAIN VALLEY MD | 0,002 | -50,00 % | Mountain Valley MD Holdings Inc: Mountain Valley hopes for continued growth in 2025 | ||
CO-DIAGNOSTICS | 0,242 | +4,31 % | Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results | SALT LAKE CITY, March 27, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the... ► Artikel lesen | |
CYTOSORBENTS | 0,981 | -1,70 % | Cytosorbents Corp: CytoSorbents Files Appeal with U.S. FDA for Supervisory Review of its De Novo Request for DrugSorb-ATR | PRINCETON, N.J., June 24, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive... ► Artikel lesen | |
VERU | 0,565 | +1,07 % | Veru Inc.: Veru Reports Positive Results from Phase 2b QUALITY and Maintenance Extension Study Showing Enobosarm Significantly Reduced Body Weight Regain, Prevented Fat Regain, and Preserved Lean Mass After Semaglutide Discontinuation | --During the Maintenance Period of 12 weeks after discontinuing semaglutide (GLP-1 receptor agonist), placebo group regained 43% of body weight that was previously lost during Phase 2b QUALITY study... ► Artikel lesen | |
TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics: Tempest Reports First Quarter 2025 Financial Results and Provides Business Update | Presented new amezalpat mechanism-of-action data reinforcing its potential as a novel cancer treatment at the 2025 AACR Annual MeetingGranted Orphan Drug designation by FDA for TPST-1495 for the treatment... ► Artikel lesen | |
VOLITIONRX | 0,750 | 0,00 % | VOLITIONRX LTD - 8-K, Current Report | ||
EKSO BIONICS | 3,400 | -5,56 % | XFRA 23E0: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILEKSO BIONICS. NEW... ► Artikel lesen | |
IMUNON | 0,665 | -2,92 % | H.C. Wainwright reiterates buy rating on Imunon stock at $14 target | ||
BEYOND AIR | 0,146 | +3,55 % | Beyond Air-Aktionäre genehmigen Reverse-Aktiensplit | ||
AVINGER | 0,340 | -6,08 % | NSE - Avinger Inc - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
NOVACYT | 0,492 | +1,97 % | Novacyt S.A. - Result of AGM | ||
AROVELLA THERAPEUTICS | 0,071 | +11,90 % | AROVELLA THERAPEUTICS LIMITED: Application for quotation of securities - ALA |